EraGen Biosciences said today that the US Food and Drug Administration has granted 510(k) market clearance for EraGen's MultiCode-RTx HSV 1&2 kit.

The MultiCode-RTx HSV 1&2 kit is a PCR-based qualitative in vitro diagnostic test for detecting and typing herpes simplex virus 1 and 2 DNA in vaginal lesions from symptomatic female patients to aid in diagnosis of genital herpes.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.